What is the future?

Dimitris Rigopoulos, Antonella Tosti

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The major problem when treating nail psoriasis is either the difficulty of the topical medications to present their therapeutic efficacy or the side effects of the systematically administrated drugs. Topical medications must penetrate the nail plate which in normal conditions presents unique barrier properties, taking in consideration also that in psoriasis it can be thickened due to the hyperkeratosis of the nail bed, increasing difficulties in acting properly. Systemic drugs have three major problems. The first has to deal with side effects of these drugs, the second with interactions with other systemic medications that these patients are probably receiving, and the third with the lack of on-label indication for nail psoriasis. The latter is a major problem when the patient has isolated nail involvement.

Original languageEnglish (US)
Title of host publicationNail Psoriasis: From A to Z
PublisherSpringer International Publishing
Pages157-159
Number of pages3
ISBN (Print)9783319088105, 9783319088099
DOIs
StatePublished - Jan 1 2014

Fingerprint

Nails
Psoriasis
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rigopoulos, D., & Tosti, A. (2014). What is the future? In Nail Psoriasis: From A to Z (pp. 157-159). Springer International Publishing. https://doi.org/10.1007/978-3-319-08810-5_16

What is the future? / Rigopoulos, Dimitris; Tosti, Antonella.

Nail Psoriasis: From A to Z. Springer International Publishing, 2014. p. 157-159.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rigopoulos, D & Tosti, A 2014, What is the future? in Nail Psoriasis: From A to Z. Springer International Publishing, pp. 157-159. https://doi.org/10.1007/978-3-319-08810-5_16
Rigopoulos D, Tosti A. What is the future? In Nail Psoriasis: From A to Z. Springer International Publishing. 2014. p. 157-159 https://doi.org/10.1007/978-3-319-08810-5_16
Rigopoulos, Dimitris ; Tosti, Antonella. / What is the future?. Nail Psoriasis: From A to Z. Springer International Publishing, 2014. pp. 157-159
@inbook{8559d3c2bf5148bebe59eb670f2b160a,
title = "What is the future?",
abstract = "The major problem when treating nail psoriasis is either the difficulty of the topical medications to present their therapeutic efficacy or the side effects of the systematically administrated drugs. Topical medications must penetrate the nail plate which in normal conditions presents unique barrier properties, taking in consideration also that in psoriasis it can be thickened due to the hyperkeratosis of the nail bed, increasing difficulties in acting properly. Systemic drugs have three major problems. The first has to deal with side effects of these drugs, the second with interactions with other systemic medications that these patients are probably receiving, and the third with the lack of on-label indication for nail psoriasis. The latter is a major problem when the patient has isolated nail involvement.",
author = "Dimitris Rigopoulos and Antonella Tosti",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-3-319-08810-5_16",
language = "English (US)",
isbn = "9783319088105",
pages = "157--159",
booktitle = "Nail Psoriasis: From A to Z",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - What is the future?

AU - Rigopoulos, Dimitris

AU - Tosti, Antonella

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The major problem when treating nail psoriasis is either the difficulty of the topical medications to present their therapeutic efficacy or the side effects of the systematically administrated drugs. Topical medications must penetrate the nail plate which in normal conditions presents unique barrier properties, taking in consideration also that in psoriasis it can be thickened due to the hyperkeratosis of the nail bed, increasing difficulties in acting properly. Systemic drugs have three major problems. The first has to deal with side effects of these drugs, the second with interactions with other systemic medications that these patients are probably receiving, and the third with the lack of on-label indication for nail psoriasis. The latter is a major problem when the patient has isolated nail involvement.

AB - The major problem when treating nail psoriasis is either the difficulty of the topical medications to present their therapeutic efficacy or the side effects of the systematically administrated drugs. Topical medications must penetrate the nail plate which in normal conditions presents unique barrier properties, taking in consideration also that in psoriasis it can be thickened due to the hyperkeratosis of the nail bed, increasing difficulties in acting properly. Systemic drugs have three major problems. The first has to deal with side effects of these drugs, the second with interactions with other systemic medications that these patients are probably receiving, and the third with the lack of on-label indication for nail psoriasis. The latter is a major problem when the patient has isolated nail involvement.

UR - http://www.scopus.com/inward/record.url?scp=84956602914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956602914&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-08810-5_16

DO - 10.1007/978-3-319-08810-5_16

M3 - Chapter

SN - 9783319088105

SN - 9783319088099

SP - 157

EP - 159

BT - Nail Psoriasis: From A to Z

PB - Springer International Publishing

ER -